The recently published article, "The Trends and Complexities of Provider-Administered Drugs" courtesy of Magellan Rx, states that with approximately 50 percent of the $124 billion annual specialty drug spend is billed on the medical benefit. Magellan continues to study this trend displayed in their Medical Pharmacy Trend Report. This report continues to be the only publication of its kind to analyze high-cost injectable drugs paid under medical benefits.
Need to know more? Find the full article HERE.
HORIZON Health Ventures is a healthcare cost management solutions company used by insurance
brokers, employee benefit consultants, third-party administrators,
insurance companies, and associations, to bring proven thought
leadership and strategy to the management of their clients healthcare
costs. To learn more about HHV and their services, please visit http://horizonhealthventures.com/
No comments:
Post a Comment